Find Out If You Need A Zyprexa Lawyer

Kahn Gauthier Swick is investigating possible legal actions against Eli Lilly and Company, the manufacturer of the prescription drug Zyprexa (olanzapine), on behalf of patients prescribed Zyprexa who have developed diabetes, hyperglycemia (elevated blood sugar), and other blood sugar disorders as a result using Zyprexa.

Approximately three million Americans suffer from bipolar disorder, while some 2.5 million have schizophrenia. Approximately one percent of the population develops schizophrenia during their lifetime.

Zyprexa has its own dangers: blood chemistry changes leading to diabetes, hyperglycemia, and other blood sugar disorders. On September 15, 2003, the federal Food and Drug Administration ordered Lilly to add warning language concerning these risks to the Zyprexa product label. This Zyprexa language was also added to the product labels for the other atypical antipsychotics.

The chief advantage of atypical antipsychotics over older antipsychotic drugs is that the newer medications like Zyprexa are less likely to cause movement disorders such as akathisia (restlessness), dystonia (muscular spasms of the neck, eyes, tongue, or jaw), Drug-Induced Parkinsonian Syndrome (muscle stiffness, shuffling gait, drooling, and tremor), and tardive dyskinesia.

Have you developed diabetes for the first time, or has your existing diabetes worsened, or have you suffered from pancreatitis or ketoacidosis since you began taking Zyprexa? If so, contact a Zyprexa lawyer today.